New Leaf Venture Partners — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Qlaris Bioqlaris.bioinMay 2024 · $24M
Qlaris Bio is a clinical-stage biotechnology company developing therapies for ophthalmology conditions.
BiotechMedical DevicesDedham, US
Thurein Htoo(Executive Officer, Director)Fred Guerard(President & Chief Executive Officer)Barbara Wirostko(Executive Officer)
BoardWende Hutton(Director)inRonald M. Hunt(Director)Andrew Danielson(Director)
Co-investorsCanaan Partnersabrdn plcCorrelation VenturesMayo Clinic Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.